This is an important issue, since G-CSF is used not only to treat different types of CN, but is also applied for chemotherapy-induced neutropenia and to induce mobilization of CD34+ stem and progenitor cells for autologous or allogeneic transplantation. This evidence concerns the gene CSF3 and Decreased total neutrophil count.